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Introduction: Elderly breast cancer patients have been shown to be managed less aggres-
sively than younger patients. There is evidence that their management varies between
institutions. We audited the management of elderly patients in two neighboring units in
Glasgow and aimed to identify reasons for any differences in practice found.
Methods: Patients aged ≥70 years, who were managed for a new diagnosis of breast cancer
in the two units between 2009 and 2013, were identiﬁed from a prospectively maintained
database. Tumor pathology, treatment details, postcode and consultant in charge of care were
obtained from the same database. Comorbidities were obtained from each patient’s electronic
clinical record. Questionnaires were distributed to members of each multidisciplinary teams.
Results: 487 elderly patients in Unit 1 and 467 in Unit 2 were identiﬁed. 76.2% patients in
Unit 1 were managed surgically compared to 63.7% in Unit 2 (p<0.0001). There was no
difference between the two units in patient age, tumor pathology, deprivation or comorbidity.
16.2% patients managed surgically in Unit 1 had a comorbidity score of 6 and above
compared to 11% of surgically managed patients in Unit 2 (p=0.036). Responses to ques-
tionnaires suggested that staff at Unit 1 were more conﬁdent of the safety of general
anesthetic in elderly patients and were more willing to consider local anesthetic procedures.
Conclusion: A higher proportion of patients aged >70 years with breast cancer were
managed surgically in Unit 1 compared to Unit 2. Reasons for variation in practice seem
to be related to attitudes of medical professionals toward surgery in the elderly, rather than
patient or pathological factors.
Keywords: breast cancer, old age, variation in treatment
Introduction
Approximately one-third (33.7% in 2012–2014) of female breast cancer cases in the
UK are diagnosed in people aged ≥70 years, and breast cancer incidence rates are
highest in people aged ≥85 years.1 Older breast cancer patients are more likely to
suffer comorbidities and frailty. For these patients, deemed not ﬁt for surgery, there
is the option of nonsurgical treatment, usually in the form of primary endocrine
therapy (PET) for those with ER-positive disease, which is present in the majority
of patients in this age group.2–4
Guidelines are clear that age should not be a factor in treatment decisions.5,6
The reported 30-day mortality following standard breast surgery is negligible.7
Despite this, there is evidence that elderly patients are sometimes treated less
aggressively than younger patients8–10 and that management varies between
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institutions.11 Patients aged >70 years are less likely to
have surgical management of their breast cancer and are
less likely to receive adjuvant radiotherapy.12,13
In Glasgow, breast cancer patients are managed in
three separate units, depending on geographical location.
We aimed to audit the management of breast cancer
patients aged ≥70 years in two of these units, which have
3 consultant surgeons each, with separate multidisciplinary
teams (MDTs). Both units serve similar populations. Our
secondary aim was to identify reasons for any differences
in practice observed.
Methods
Patients who were managed for breast cancer between
2009 and 2013 at either the Western Inﬁrmary (Unit 1)
or Victoria Inﬁrmary (Unit 2) in Glasgow were identi-
ﬁed from a prospectively maintained database within the
West of Scotland Managed Clinical Network. Data col-
lection within this network is systematic and its stan-
dards are checked regularly. Those patients aged <70
years at the date of diagnosis were excluded. Data
regarding clinicopathological characteristics, hospital of
treatment, consultant in charge of care and treatment
received were collected from the same database. The
postcode obtained from this database for each patient
was used to determine the Scottish Index of Multiple
Deprivation 2012 (SIMD) score. The SIMD ranks small
areas from most deprived to least deprived by combin-
ing 38 indicators across seven weighted domains
(income, employment, health, education, skills and train-
ing, housing, geographic access and crime).14 For the
sake of our analysis, we then divided these rankings into
quintiles.
Comorbidity data were collected from each patient’s
electronic clinical record. Clinic letters, pre-assessment
forms and diagnosis codes within GP referral letters,
which preceded the date of diagnosis of breast cancer,
were examined by hand by EM to identify comorbid
diagnoses for each patient. These were then used to calcu-
late the Charlson comorbidity index (CCI). The CCI is
a combined age-comorbidity score, devised as a predictor
of mortality.15 In addition, surrogate marker of comorbid-
ity, number of inpatient bed days in the two years preced-
ing diagnosis, and number of emergency admissions in
the year preceding diagnosis, were obtained for each
patient from the National Services Scotland Information
Services Division, within the SMR01-General/Acute
Inpatient and Day Case database. Approval for this was
obtained from the Caldicott Guardian for NHS Greater
Glasgow & Clyde.
To ascertain the attitudes of medical staff on each site,
questionnaires were designed and distributed via e-mail to
all staff who were members of the MDT on each site for
part or all of the time between 2009 and 2013. The design
of the questionnaires was based on those used in previous
work by Morgan et al.16 They were returned and responses
analyzed anonymously. A sample of the questionnaire is
attached as Supplementary material.
All data analysis was carried out in SPSS version 22.0
(IBM Corp, Armonk, NY, USA). Graphs were created in
Microsoft Excel 2016 (Microsoft Corporation, Redmond,
WA, USA). Chi-square test was used for comparisons.
Results
Management in the two units
In total, 3,850 patients were treated for breast cancer at the
two units over the 5-year period. 954 patients were aged
≥70 years at the time of diagnosis so were included in the
study. 487 patients were treated at Unit 1 and 467 patients
were treated at Unit 2. Treatment regimens involved dif-
ferent combinations of surgery, endocrine therapy, radio-
therapy and chemotherapy with 16 different combinations
used altogether. These combinations were simpliﬁed to
those whose initial management plan included surgery at
any point, involved endocrine treatment only and other.
Over the 5-year period, 371 (76.2%) patients were mana-
ged surgically in Unit 1, compared to 300 (63.7%) patients
in Unit 2 (p<0.0001). When broken down by year, this
difference was maintained throughout, though was not
statistically signiﬁcant in 2011 or 2012 (Figure 1).
Clinicopathological characteristics
The median age of patients in both units was 77 years
(range 70–97 years Unit 1, 70–101 years Unit 2). There
was no difference between the two units in tumor patho-
logical characteristics, namely histological type, clinical
T stage, tumor grade, number of involved lymph nodes,
estrogen status or human epidermal growth factor 2 status
(Table 1).
Deprivation
SIMD scores were available for 445 patients from Unit 1
and 433 patients from Unit 2. Within each unit, they were
divided into quintiles, with quintile 1 representing the
most deprived patients and quintile 5, the least deprived.
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107 (24.0%) Unit 1 patients were in quintile 1 compared to
108 (24.9%) of Unit 2 patients. 110 (24.7%) of Unit 1
patients were in quintile 5 compared to 113 (26.1%) Unit 2
patients. Overall, there was no difference in levels of
deprivation demonstrated between the two units (Table 1).
Comorbidity
No difference in CCI was seen overall between the two
units. Both units had a median CCI of 4 (range 3–13 Unit
1, 3–11 Unit 2). However, a difference in CCI was seen in
patients who were managed surgically in each unit. When
grouped into low (3–5), medium (6–9) and high (10+) CCI
groups, a higher proportion of Unit 1 surgical patients
(16.2%) were in the two higher comorbidity groups com-
pared to Unit 2 (11%) (p=0.036) (Table 2).
There was no difference between the two units in
median number of emergency admissions for patients in
the year preceding diagnosis (Unit 1: 0 [0–6], Unit 2: 0
[0–7]). Similarly, there was no difference demonstrated
between the two units in terms of inpatient days per patient
in the two years preceding diagnosis (Unit 1: median 0
[0–232], Unit 2: 0 [0–327]). 66.1% patients in Unit 1 had 0
inpatient days compared to 64.5% for Unit 2. For 1–7
inpatient days, it was 19.5% and 19.1%, respectively, for
8–21 days 8.4% and 8.8%, for 22–90 days 4.7% and 5.8%
and 1.2% and 1.9% had more than 90 inpatient days.
Attitudes of health care staff
The questionnaire was distributed by e-mail to 29 people on
two separate occasions. There were 18 respondents, 6 from
Unit 1 (3 surgeons, 1 breast care nurse and 2 oncologists), 11
fromUnit 2 (3 surgeons, 2 breast care nurses, 2 oncologists, 2
radiologists, 1 pathologist and 1 anesthetist) and 1 (radiolo-
gist) who covered both sites equally so was excluded from
comparative analysis. There was little difference in the
responses to most of the questions in the questionnaire
between the two sites. However, there was a suggestion of
a stronger feeling amongst staff in Unit 1 that surgery is
superior to PET, compared to Unit 2 (Figure 2A). Staff in
Unit 1 felt more strongly that general anesthetic (GA) is safe
in elderly breast cancer patients (Figure 2B) and seem more
willing to perform a wide local excision under local anes-
thetic (Figure 2C).
There was general agreement that comorbidities (17/
17) (with respondents rating it as very or moderately
important), life expectancy (17/17), patient choice (16/
16), frailty (16/16) and dementia (16/17) were the most
important factors in deciding whether a patient should
undergo surgery with age and family preference felt to
be the least important factors (Figure 3). Assessment
tools used to help make these decisions were most com-
monly “end of the bed test” or simple tests such as walk-
ing up a ﬂight of stairs, while formal comprehensive
geriatric assessments were rarely used (Figure 4).
Discussion
In this study, we report a signiﬁcant difference in the rates
of surgical treatment of breast cancer, in patients aged ≥70
years, at two neighboring city hospitals. There was no
difference in patient or tumor factors between the two
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Figure 1 Proportion of patients in each unit who received surgical treatment, endocrine therapy only or other treatment modality, by year of diagnosis. Difference in rates
of surgery: 2009 p=0.007, 2010 p=0.005, 2011 p=0.075, 2012 p=0.430, 2013 p=0.016, altogether p<0.0001.
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cohorts to explain this difference. Unit 1 operated on
a higher proportion of patients with high levels of comor-
bidity than Unit 2, which may be explained by differences
in attitudes of health professionals towards surgery in the
elderly.
Our ﬁndings are in keeping with a number of other studies
which have reported variation in the rates of surgical manage-
ment of breast cancer in the elderly. It is known that elderly
patients are often treated less aggressively for breast cancer
than their younger counterparts. Several studies have reported
lower rates of surgical treatment with increasing age.8,10,17–21
Most recently, the National Audit of Breast Cancer in Older
Patients (NABCOP) 2017 Annual Report reported rates of
breast cancer surgery of 90% in patients aged 50–74 years
which fell to 15% in those aged >90, between 2011 and
2015.21 It has been reported that axillary surgery is less
aggressive in older age groups,17,19,20 and rates of adjuvant
treatment fall with increasing age.3,17,19,20,22 These differences
have been reported despite adjustment for tumor
characteristics,20 levels of comorbidity and functional
status23,24 and patient choice.25 A 2007 review by
Bouchardy et al described rates of substandard treatments
from 13% to 57% in older women.24
Our key ﬁnding in this study is the difference in rates
of surgical treatment of patients aged ≥70 years between
the two units studied. Regional variation in surgical man-
agement of breast cancer in older patients has been
reported previously. Data from other countries in Europe
describe higher surgical rates in elderly patients than those
in the UK.17–19 A Canadian study reported that all of their
patients with stage I–III primary breast cancer aged ≥70
years underwent surgery in some form9 and only 1.7% of
patients in an American study of 49,616 women did not
undergo surgery.3 Beyond these international differences,
variation in surgical management of older patients has also
been reported between different regions of the UK, even
after adjustment for case mix.11,21,26 The Breast Cancer
Clinical Outcome Measures (BCCOM) project reported
rates of nonsurgical treatment which ranged from 12% to
40% across different regions of England and Wales.26
A national interview and questionnaire-based study
reported variable rates of PET use, ranging from 37.9%
respondents using PET in <10% women ≥70 years to 7.1%
saying they used it in >30% women.16 The results of our
study add to this body of evidence by reporting that this
Table 1 Pathological characteristics of breast cancers and SIMD
quintile of patients treated within each unit
Characteristics Unit 1
n (%)
Unit 2
n(%)
p-value
Histological type (n=468/
438)
DCIS
Ductal/NST
Lobular
Other
29 (6.2)
345
(73.6)
62 (13.2)
32 (6.8)
29 (6.6)
346
(78.8)
48 (10.9)
15 (3.4)
0.892
Tumour size (n=325/238)
T1
T2
T3
161
(49.4)
136
(41.7)
28 (8.6)
105
(43.9)
118
(49.4)
15 (6.3)
0.232
Gradea (n=321/239)
1
2
3
31 (9.6)
163
(50.6)
127
(39.4)
13 (5.4)
124
(51.7)
102
(42.5)
0.487
Involved nodes (n=405/367)
0
1–3
>3
303
(74.8)
65 (16.1)
37 (9.1)
293
(79.6)
51 (13.9)
23 (6.3)
0.103
ER status (n= 435/405)
Negative
Positive
48 (11.0)
387
(88.8)
50 (12.3)
355
(87.4)
0.591
HER2 status (n=431/382)
Negative
Positive
380
(88.2)
51 (11.8)
333
(87.2)
49 (12.8)
0.670
SIMD quintile (n=445/433)
1
2
3
4
5
107
(24.0)
74 (16.6)
66 (14.8)
88 (19.8)
110
(24.7)
108
(24.9)
59 (13.6)
47 (10.9)
106
(24.5)
113
(26.1)
0.169
Note: a Invasive only.
Abbreviations: ER, estrogen receptor; HER2, human epidermal growth receptor
2; SIMD, Scottish Index of Multiple Deprivation.
Table 2 Distribution of Charlson Comorbidity Index scores for
patients who underwent surgery in each unit
Charlson Comorbidity Index Number of patients
(% within unit)
Unit 1 Unit 2
3–5 310 (83.8) 258 (89.0)
6–9 57 (15.4) 32 (11.0)
10+ 3 (0.8) 0 (0)
Note: p=0.036.
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variability in treatment is not only international or regio-
nal, but even extends to adjacent hospitals within the same
health board.
Our results showed that Unit 1 operated on patients with
higher levels of comorbidity. The questionnaire results sug-
gest that it may be differences in attitudes of health profes-
sionals which are responsible for this variation. Members of
the Unit 1 MDTwere more conﬁdent in the safety of general
anesthetic in elderly patients, supported in this view by
a perioperative mortality rate of 0% over the study period,
and were more willing to carry out breast-conserving surgery
under local anesthetic. These differences may have a number
of explanations, including differences in training and experi-
ence of the surgeons and anesthetist. It should also be noted,
however, that while an equal number of respondents from
each unit were surgeons, they made up a higher proportion of
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Figure 2 Responses of health professionals in each unit to the statement: (A) “surgery is superior to PET in elderly patients”; n=15, p=0.092. (B) “surgery under general
anaesthetic (GA) is generally safe in elderly breast cancer patients”; n=16, p=0.002. (C) “I would be happy to perform wide local excision under local anaesthetic for an
elderly patient deemed high risk for GA”; n=7, p=0.118.
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Figure 3 Factors considered by health professionals in both units to be “moderately” or “very important” in determining whether an elderly patient undergoes surgery.
Abbreviations: ER, estrogen receptor; HER2, human epidermal growth receptor 2.
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total respondents from Unit 1 which may affect these results.
While guidelines clearly state that the decision regarding
treatment should not be based on age but on ﬁtness for
surgery,6 there is a paucity of guidelines regarding who
should be regarded as ﬁt. Our results also show that objective
measures of ﬁtness for surgery are rarely used in this setting.
A previous study involving questionnaires and interviews
with health professionals nationwide reported similar results.
As in our study, most respondents felt that level of comor-
bidity, frailty and life expectancy were more important than
age in decision-making, while opinion was divided regarding
dementia. As in our study, there was variable experience with
local and regional anaesthetic.16
Another factor which could inﬂuence patient management
is patient choice, whichwas impossible to reliably assess retro-
spectively in this study. However, some studies have suggested
that patient preference is not a strong factor in determining
management in this patient group. Lavelle et al reported that
patients’ role in decision-making made no difference to
whether they had surgery or not.25 A review by Bouchardy
et al reported that only a small proportion of patients refused all
or part of their proposed treatment, a minority of patients were
prepared to consider lighter treatment and refusal rates for
clinical trials were similar for all ages.24 In contrast to this,
Vetter et al reported that 13% patients aged >80 years refused
endocrine therapywhen it was recommended and 49% refused
radiotherapy.19 Similarly, Hamaker et al reported that patient
choice was the reason for omitting surgery in 32% patients
aged ≥75 years.18
Other limitations of this study include its retrospective
nature. Though details of tumor characteristics and treatment
are recorded prospectively, there is a reliance on accurate
coding of data. Comorbidity data were collected retrospec-
tively, but a number of sources within the electronic clinical
record were used to optimize retrieval of diagnoses. The
questionnaires required practitioners to respond to questions
in the present relating to their attitudes and practice several
years ago. These may have changed over time and ﬁndings
may be subject to recall bias. There was a 62% response rate
but 100% surgeons responded. As a measure of comorbidity,
the CCI is limited in that it measures a diagnosis and not the
extent to which that diagnosis limits the patient functionally,
neither does it assess frailty. For this reason, we employed
a second, surrogate marker of comorbidity, inpatient bed days
and emergency admissions, as this may provide a clearer
representation of a patient’s function and frailty in the years
immediately preceding to diagnosis. Statistically, our study is
limited by sample size, particularly as regards analysis of
questionnaire results, but this was unavoidable since the aim
of our study was to investigate whether the known regional
variation in the management of breast cancer in the elderly
was born out in two neighboring hospitals where it might be
expected that practice would be similar.
Conclusion
A higher proportion of patients aged >70 years with breast
cancer were managed surgically in Unit 1 compared to Unit 2.
Reasons for variation in practice seem to be related to attitudes
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Figure 4 Responses of health professionals in both units to the question “in your practice, how frequently do you use the following tests to assess ﬁtness for surgery in
elderly patients?”
Abbreviation: CGA, complex geriatric assessment.
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of medical professionals toward surgery in the elderly, rather
than patient or pathological factors. Further research and
guidelines are required to aid practitioners in deciding who is
ﬁt for surgery, to improve uniformity of treatment.
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Supplementary material
In each case, please replace the relevant □ with “X”.
NB. For the purposes of this questionnaire, “elderly” is deﬁned as age ≥70 years.
Of which MDT were you a member?
West □ South □
Over what time period between 2009 and 2013 were you a member of that MDT?
–––––––––––––––––––––––––
What was your role on the MDT during the above time period?
Surgeon□ BC nurse□ Oncologist□ Radiologist□ Pathologist□ Anaesthetist□ Other □
Attitudes to surgery
Please indicate the degree to which you agree with the following statements.
1. Surgery is superior to PET in elderly patients.
Strongly agree □ Agree □ Unsure □ Disagree□ Strongly disagree□
2. All women aged >70 years should be offered an operation regardless of age.
Strongly agree □ Agree □ Unsure □ Disagree □ Strongly disagree □
3. Surgery under general anesthesia (GA) is generally safe in elderly breast cancer patients.
Strongly agree □ Agree □ Unsure □ Disagree□ Strongly disagree □
4. I would be happy to perform wide local excision under local anesthetic for an elderly patient deemed high risk for GA.
Strongly agree □ Agree □ Unsure □ Disagree □ Strongly disagree □ Not applicable to me □
5. I would be happy to carry out mastectomy under LA for an elderly patient deemed high risk for GA.
Strongly agree □ Agree □ Unsure □ Disagree □ Strongly disagree □ Not applicable to me □
6. In my institution, there would be no difﬁculty in arranging for an anesthetist to carry out a regional block for breast cancer surgery.
Strongly agree □ Agree □ Unsure □ Disagree □ Strongly disagree □ Not applicable to me □
Attitudes to PET
7. In your experience, how effective is PET at managing breast cancer in the elderly?
Very effective □ Reasonably effective □ Equivocal □ Not particularly □ Not at all □
Please indicate the degree to which you agree with the following statements.
8. PET should be offered to all ER-positive patients over 70 years.
Strongly agree □ Agree □ Unsure □ Disagree □ Strongly disagree □
Perception of patient preference
9. Given the choice, most elderly patients would opt for surgery rather than PET.
Strongly agree □ Agree □ Unsure □ Disagree □ Strongly disagree □
Assessment tools and important factors
10. In your practice, how frequently do you use the following tests to assess ﬁtness for surgery in elderly patients? (If not applicable, please
skip to question 11.)
a) End of the bed test
Always □ Frequently □ Sometimes □ Rarely/Seldom □ Never □
b) Simple tests, eg, walk up ﬂight of stairs
Always □ Frequently □ Sometimes □ Rarely/Seldom □ Never □
c) Formal anesthetic assessment
Always □ Frequently □ Sometimes □ Rarely/Seldom □ Never □
d) Comprehensive geriatric assessments
Always □ Frequently □ Sometimes □ Rarely/Seldom □ Never □
11. In your opinion, how important are the following factors in determining whether an elderly patient undergoes surgery or not?
a) ER status
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
b) HER-2 status
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
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c) Tumor size
Very Important □ Moderately important □ Equivocal □ Not very
important □ Not at all important
d) Axillary disease
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
e) Age
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
f) Comorbidities
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
g) Frailty
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
h) Dementia
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
i) Patient choice
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
j) Life expectancy
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
k) Functional status
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
l) Anxiety about surgery
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
m) Anxiety about breast cancer
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
n) Family preference
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
12. In your experience, how important are the following factors in explaining the wide variation in treatment for elderly patients with breast
cancer?
a) Medical staff attitudes
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
b) Patient attitudes
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
c) Lack of guidelines
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
d) More variability in patients/heterogeneous group
Very Important □ Moderately important □ Equivocal □ Not very important □ Not at all important
13. Please use the box below to provide any other comments you have on this subject.
Many thanks for taking the time to complete this questionnaire.
Please write comments here.
Figure S1Questionnaire for MDT members Western Inﬁrmary & Victoria Inﬁrmary 2009–2013.
Abbreviations: BC, board certiﬁed; ER, estrogen receptor; HER2, human epidermal growth receptor 2; LA, local anethesia; MDT,multidisciplinary team; PET, primary endocrine therapy.
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